首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis
【24h】

Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis

机译:胰腺神经内分泌癌变小鼠模型中肿瘤侵袭的多态遗传控制

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer is a disease subject to both genetic and environmental influences. In this study, we used the RIP1-Tag2 (RT2) mouse model of islet cell carcinogenesis to identify a genetic locus that influences tumor progression to an invasive growth state. RT2 mice inbred into the CS7BL/6 (S6) background develop both non-invasive pancreatic neuroendocrine tumors (PNET) and invasive carcinomas with varying degrees of aggressiveness. In contrast, RT2 mice inbred into the C3HeB/Fe (C3H) background are comparatively resistant to the development of invasive tumors, as are RT2 C3HB6(F1) hybrid mice. Using linkage analysis, we identified a 13-Mb locus on mouse chromosome 17 with significant linkage to the development of highly invasive PNETs. A gene residing in this locus, the anaplastic lymphoma kinase (Alk), was expressed at significantly lower levels in PNETs from invasion-resistant C3H mice compared with invasion-susceptible B6 mice, and pharmacological inhibition of Alk led to reduced tumor invasiveness in RT2 B6 mice. Collectively, our results demonstrate that tumor invasion is subject to polymorphic genetic control and identify Alk as a genetic modifier of invasive tumor growth.
机译:癌症是受遗传和环境影响的疾病。在这项研究中,我们使用了胰岛细胞癌变的RIP1-Tag2(RT2)小鼠模型来鉴定影响肿瘤进展为侵袭性生长状态的遗传位点。近交进入CS7BL / 6(S6)背景的RT2小鼠会发展成非侵袭性胰腺神经内分泌肿瘤(PNET)和侵袭性癌症,侵袭程度不同。相反,近交繁殖入C3HeB / Fe(C3H)背景的RT2小鼠对侵袭性肿瘤的发展具有相对的抵抗力,RT2 C3HB6(F1)杂交小鼠也是如此。使用连锁分析,我们在小鼠染色体17上鉴定出13-Mb基因座与高侵害性PNET的发展具有显着连锁关系。与易受侵袭的B6小鼠相比,存在于该基因座的基因,间变性淋巴瘤激酶(Alk)在耐侵袭性C3H小鼠的PNETs中表达水平明显低于易受侵袭的B6小鼠,并且药理学抑制Alk导致RT2 B6的肿瘤侵袭性降低老鼠。总体而言,我们的结果表明,肿瘤浸润受多态性遗传控制,并确定Alk是浸润性肿瘤生长的遗传修饰因子。

著录项

  • 来源
  • 作者单位

    Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143 Diabetes Center, University of California, San Francisco, CA 94143 Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143 Program in Biological Sciences, University of California, San Francisco, CA 94158;

    rnHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143 Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720;

    rnDiabetes Center, University of California, San Francisco, CA 94143 Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143;

    rnHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143;

    rnDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94143 Diabetes Center, University of California, San Francisco, CA 94143 Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143 Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Lausanne, Lausanne CH-1015, Switzerland;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    anaplastic lymphoma kinase; cancer modifier genes; malignant progression; pancreas cancer; transgenic mouse;

    机译:间变性淋巴瘤激酶癌症修饰基因恶性进展;胰腺癌转基因小鼠;
  • 入库时间 2022-08-18 00:41:27

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号